Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Schalli, M; Tysoe, C; Fischer, R; Pabst, BM; Thonhofer, M; Paschke, E; Rappitsch, T; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG.
N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a GM1-gangliosidosis related human lysosomal β-galactosidase mutant.
Carbohydr Res. 2017; 443-444(15):15-22
Doi: 10.1016/j.carres.2017.03.009
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Schalli Michael
- Co-Autor*innen der Med Uni Graz
-
Pabst Bettina
-
Paschke Eduard
-
Tschernutter Marion
-
Windischhofer Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
From 1,2;3,4-di-O-isopropylidene-α-D-galactopyranose, a series of highly functionalized (hydroxymethyl)cyclopentanes was easily available. In line with reports by Reymond and Jäger on similar structures, these amine containing basic carbasugars are potent inhibitors of β-D-galactosidases and, for the first time, could be shown to act as pharmacological chaperones for GM1-gangliosidosis-associated lysosomal acid β-galactosidase mutant R201C, thus representing a new structural type of pharmacological chaperones for this lysosomal storage disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
-
Cyclopentanes - chemical synthesis
-
Cyclopentanes - chemistry
-
Cyclopentanes - pharmacology
-
Enzyme Inhibitors - chemical synthesis
-
Enzyme Inhibitors - chemistry
-
Enzyme Inhibitors - pharmacology
-
Gangliosidosis, GM1 - enzymology
-
Gangliosidosis, GM1 - genetics
-
Humans -
-
Models, Molecular -
-
Molecular Conformation -
-
Mutation -
-
beta-Galactosidase - antagonists & inhibitors
-
beta-Galactosidase - genetics
- Find related publications in this database (Keywords)
-
Aminocyclopentane
-
Carbafuranose
-
Galactosidase inhibitor
-
Pharmacological chaperone
-
G(M1)-Gangliosidosis